In this capacity, he discussed potential projects with and has signed/signs contracts for his institute(s) and for the staff for research funding and/or collaborations with industry and academia, worldwide, including but not limited to pharmaceutical corporations such as Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Medigene, Arbormed, BioSyngen and others
Kaiser Family Foundation (KFF) , Medicaid coverage of GLP-1 drugs for weight loss (2024) coverage statistics ( [24] )
In case you are interested and have another 3 minutes, here I will elaborate more on why pharma companies need to move with the times and embrace the significant benefits, both to patients and their bottom line, by truly engaging with the individual patient via new technologies like apps
Our comparison resources covering semaglutide versus tirzepatide , their side effect profiles , dosage chart comparisons , survodutide versus tirzepatide , cagrisema versus tirzepatide , orforglipron versus tirzepatide , and mazdutide versus tirzepatide provide the pharmacological context needed for designing comparative studies
Cardiovasc Diabetol 21(1):169 Nauck MA, Meier JJ (2019) Management of endocrine disease: Are all GLP-1 agonists equal in the treatment of type 2 diabetes
Mostafa, G